BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7860358)

  • 1. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility.
    Partanen J; Peterson P; Westman P; Aranko S; Krohn K
    Hum Immunol; 1994 Oct; 41(2):135-40. PubMed ID: 7860358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant suppression of Addison's disease associated with HLA-B15.
    Baker PR; Baschal EE; Fain PR; Nanduri P; Triolo TM; Siebert JC; Armstrong TK; Babu SR; Rewers MJ; Gottlieb PA; Barker JM; Eisenbarth GS
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2154-62. PubMed ID: 21565792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA similarities indicate shared genetic risk in 21-hydroxylase autoantibody positive South African and United States Addison's disease.
    Ross IL; Babu S; Armstrong T; Zhang L; Schatz D; Pugliese A; Eisenbarth G; Baker Ii P
    Tissue Antigens; 2014 Oct; 84(4):361-9. PubMed ID: 25040682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium.
    Baker P; Fain P; Kahles H; Yu L; Hutton J; Wenzlau J; Rewers M; Badenhoop K; Eisenbarth G
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1573-8. PubMed ID: 22723331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.
    Gambelunghe G; Falorni A; Ghaderi M; Laureti S; Tortoioli C; Santeusanio F; Brunetti P; Sanjeevi CB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3701-7. PubMed ID: 10523017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
    Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
    Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1.
    Bøe AS; Bredholt G; Knappskog PM; Hjelmervik TO; Mellgren G; Winqvist O; Kämpe O; Husebye ES
    Eur J Endocrinol; 2004 Jan; 150(1):49-56. PubMed ID: 14713279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
    Myhre AG; Undlien DE; Løvås K; Uhlving S; Nedrebø BG; Fougner KJ; Trovik T; Sørheim JI; Husebye ES
    J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.
    Bratland E; Bredholt G; Mellgren G; Knappskog PM; Mozes E; Husebye ES
    J Autoimmun; 2009 Aug; 33(1):58-67. PubMed ID: 19329278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
    Falorni A; Laureti S; Nikoshkov A; Picchio ML; Hallengren B; Vandewalle CL; Gorus FK; Tortoioli C; Luthman H; Brunetti P; Santeusanio F
    Clin Exp Immunol; 1997 Feb; 107(2):341-6. PubMed ID: 9030873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.
    Bratland E; Skinningsrud B; Undlien DE; Mozes E; Husebye ES
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5117-24. PubMed ID: 19890026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease.
    Park YS; Sanjeevi CB; Robles D; Yu L; Rewers M; Gottlieb PA; Fain P; Eisenbarth GS
    Tissue Antigens; 2002 Aug; 60(2):155-63. PubMed ID: 12392510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease.
    Yu L; Brewer KW; Gates S; Wu A; Wang T; Babu SR; Gottlieb PA; Freed BM; Noble J; Erlich HA; Rewers MJ; Eisenbarth GS
    J Clin Endocrinol Metab; 1999 Jan; 84(1):328-35. PubMed ID: 9920103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease--an association study and expression analysis.
    Fichna M; Żurawek M; Bratland E; Husebye ES; Kasperlik-Załuska A; Czarnocka B; Januszkiewicz-Lewandowska D; Nowak J
    Autoimmunity; 2015 Mar; 48(2):100-7. PubMed ID: 25347332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations.
    Gombos Z; Hermann R; Kiviniemi M; Nejentsev S; Reimand K; Fadeyev V; Peterson P; Uibo R; Ilonen J
    Eur J Endocrinol; 2007 Dec; 157(6):757-61. PubMed ID: 18057383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease.
    Wolff AB; Breivik L; Hufthammer KO; Grytaas MA; Bratland E; Husebye ES; Oftedal BE
    Eur J Endocrinol; 2021 Apr; 184(4):607-615. PubMed ID: 34665570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase.
    Nikoshkov A; Falorni A; Lajic S; Laureti S; Wedell A; Lernmark K; Luthman H
    J Immunol; 1999 Feb; 162(4):2422-6. PubMed ID: 9973524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
    Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
    J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.
    Hunt PJ; Marshall SE; Weetman AP; Bunce M; Bell JI; Wass JA; Welsh KI
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):491-9. PubMed ID: 11678832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
    Uibo R; Aavik E; Peterson P; Perheentupa J; Aranko S; Pelkonen R; Krohn KJ
    J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.